Our stories

MSD publishes Purpose for Progress Impact Report 2025/2026

We’re building on measurable progress and announcing updated goals for 2030

August 18, 2026

We’re ‘seeing green’ and building a more sustainable business

Our employee-led sustainability initiative exemplifies our company's culture of operating responsibly

August 18, 2026

Understanding the health risks of high LDL cholesterol

Reducing low-density lipoprotein (LDL) cholesterol may lower the risk of heart attacks and strokes

August 11, 2026

Our Q2 2026 financial results

August 4, 2026

From crosswords to cancer research

Rebecca Goldstein applies similar problem-solving and pattern-finding skills to immuno-oncology drug discovery that she uses to create crossword puzzles in her spare time

July 22, 2026

Understanding blood cancers

How MSD is helping advance research with new approaches for people living with these challenging conditions

June 10, 2026

MSD’s One Pipeline strategy: Purpose, patients and big bets on science

Our approach to drug development aims to bring together our own innovation with the best external science so we can more quickly help patients who are counting on us

June 8, 2026